Knowledge Library Prototype
Pharmacogenomics Intelligence
Prototype collection covering precision medicine, pharmacogenomics, companion diagnostics, personalized therapeutics, genomic biomarkers, CPIC guidance, FDA pharmacogenomic labeling, clinical trials, and AJPPS research.
Featured AJPPS Research
Placeholder for AJPPS pharmacogenomics and precision medicine research.
Latest Pharmacogenomics Intelligence
Reserved for approved RSS/API content.
FDA & Precision Medicine Updates
- BsUFA IV: Fiscal Years 2028-2032
by FDA on 07/16/2026 at 5:00 pmOn September 30, 2022, the President signed into law the FDA User Fee Reauthorization Act of 2022.
- MantroForce - 729021 - 06/17/2026by FDA on 07/16/2026 at 4:35 pm
Unapproved New Drugs/Misbranded
- CDER Small Business & Industry Assistance (SBIA)by FDA on 07/16/2026 at 4:34 pm
A Comprehensive Resource for Information on Human Drug Development in Regulation
- Wholesale Peptide - 729447 - 06/17/2026by FDA on 07/16/2026 at 4:22 pm
Unapproved New Drugs/Misbranded
- Texinkart Inc. - 729046 - 06/17/2026by FDA on 07/16/2026 at 4:20 pm
Unapproved New Drugs/Misbranded
Clinical Implementation
Future integration of CPIC guidance, pharmacogenomic testing resources, implementation science, and medication optimization.
Clinical Trials Watch
Future pharmacogenomics and precision medicine trial integration.
Related Collections
- Biotechnology & Gene Therapy Intelligence
- Regulatory Science Intelligence
- FDA Approvals & Medication Safety
- Cardiology Intelligence